DEVELOPMENT ROADMAP
A deliberate path from established transcript usage analysis toward broader investigation of RNA and its genomic context.
Our current commercial service identifies and contextualizes changes in relative transcript usage in eligible human bulk RNA-seq studies.
Explore DTU analysis →A separate junction-centered capability for identifying and evaluating events beyond existing transcript annotations. The companion application is under active qualification.
Not currently offered as an independent commercial service. Developmental capabilities are not automatically included in core DTU analysis.
A future analytical direction that could combine transcript and splice-pattern observations with DNA sequencing evidence to prioritize possible genomic contributors.
Concept-stage direction. An integrated platform is not yet commercially available or validated. No release date is committed.
START A CONVERSATION
We welcome conversations about research needs and potential collaborations.